IRVING WEISSMAN, M.D. - Corporate Board Profile

Microbot Medical Inc.

Filing Date	Source Excerpt
2010-04-13	Irving Weissman, M.D., was elected to the Board of Directors in September 1997. ... Dr. Weissman, a member of the Board of Directors, was retained in September 1997 to serve as a consultant to us. ... We pay Dr. Weissman $50,000 per year for his services and we granted him, in 1997, an option to purchase 500,000 shares of common stock for $5.25 per share. ... The following table summarizes compensation information for our non-employee directors ... Irving Weissman: Total $89,300.
2011-05-17	Irving Weissman, M.D., was elected to the Board of Directors in September 1997. He serves as the chairman of the company’s Scientific Advisory Board and as a consultant. ... Director Compensation Table: Irving Weissman Fees Earned in Cash $35,000, Stock Awards $8,100, All Other Compensation $50,000, Total $93,100.
2012-04-27	Irving Weissman, M.D., was elected to the Board of Directors in September 1997. He is the Virginia and Daniel K. Ludwig Professor of Cancer Research, Professor of Pathology and Professor of Developmental Biology at Stanford University. ... Director Compensation Table shows Irving Weissman fees earned or paid in cash $35,000, Stock Awards $14,526, All Other Compensation $45,199, Total $94,725. ... Dr. Weissman receives $50,000 per year for his services as a consultant and as the chairman of our Scientific Advisory Board.
2013-10-31	Irving Weissman, M.D., was elected to the Board of Directors in September 1997. ... Dr. Weissman receives $50,000 per year for his services as a consultant and as the chairman of our Scientific Advisory Board. ... Director Compensation Table: Irving Weissman, M.D. Fees Earned or Paid in Cash $32,000, Stock Awards $20,300, All Other Compensation $50,000, Total $102,300.
2014-04-30	Irving Weissman, M.D., was elected to the Board of Directors in September 1997. He is the Virginia and Daniel K. Ludwig Professor of Cancer Research, Professor of Pathology and Professor of Developmental Biology at Stanford University. Dr. Weissman has served on our Board for over sixteen years and serves as the chairman of our Scientific Advisory Board. Director compensation table shows Irving Weissman earned $99,800 in 2013, including $50,000 per year for his services as a consultant and as the chairman of our Scientific Advisory Board.
2015-04-30	Irving Weissman, M.D., was elected to the Board of Directors in September 1997. He is the Virginia and Daniel K. Ludwig Professor of Cancer Research at Stanford University. Dr. Weissman was granted 41,301 restricted stock units on January 1, 2014, vesting on the one year anniversary of the grant. Dr. Weissman receives $50,000 per year for his services as a consultant and as the chairman of our Scientific Advisory Board. The following table summarizes cash-based and equity compensation information for our outside directors for the year ended December 31, 2014: Irving Weissman Fees Earned or Paid in Cash $34,500, Stock Awards $54,104, Other Compensation $50,000, Total $138,604.
2016-04-08	Irving Weissman, M.D., was elected to the Board of Directors in September 1997. He is the Virginia and Daniel K. Ludwig Professor of Cancer Research, Professor of Pathology and Professor of Developmental Biology at Stanford University and the Director of the Institute of Stem Cell Biology and Regenerative Medicine at Stanford. ... Dr. Weissman receives $50,000 per year for his services as a consultant and as the chairman of our Scientific Advisory Board. Since May 2011, Dr. Weissman has received his consultancy fees under this agreement in the form of company common stock. ... The following table summarizes cash-based and equity compensation information for our outside directors, including annual Board and committee retainer fees and meeting attendance fees, for the year ended December 31, 2015: ... Irving Weissman Fees Earned or Paid in Cash $39,000, Stock Awards $60,000, All Other Compensation $50,000, Total $99,000.